(Q46350021)
Statements
Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States (English)
David W Hutton
Curtis D Collins
29 January 2013
scientific article published on 29 January 2013